echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JCC: Ileocolectomy increases primary bile acids and affects the composition of the gut microbiota in ileal inflammatory and inflammatory bowel disease

    JCC: Ileocolectomy increases primary bile acids and affects the composition of the gut microbiota in ileal inflammatory and inflammatory bowel disease

    • Last Update: 2023-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recurrent intestinal inflammation after ileal resection severely affects the lives
    of most people with Crohn's disease (CD).
    Nearly 80 percent of CD patients require surgery in their lifetime, and one-third require surgery
    within five years of diagnosis.
    After surgery, 70% of patients relapse endoscopically within one year, and 25% require repeat resection
    within 5 years.
    Inflammation at the end of the ileum after ileectomy is a better predictor of patient outcomes than other sites or factors
    .
    Thus, postoperative recurrent ileitis increases the risk of CD morbidity, malnutrition, and parenteral nutrition dependence
    .
    To date, there are no data
    on the relationship between fecal bile acids, ileal resection, and intestinal inflammation revealed by ileocoloscopy.
    Because bile acids are reabsorbed at the end of the ileum, the bile acid (BA) composition may change significantly after ileal resection
    .

    Therefore, there are serious knowledge gaps
    regarding the effect of ileal resection on bile acid-mediated intestinal inflammation.
    Elevated primary bile acids have been shown to be a central component of mucosal biofilms, which have been reported to be more common in IBD and associated with
    dysbiosis.
    The effect of bile acid (BA) perturbations caused by bowel resection on the gut microbiota and inflammation is unclear
    .
    This study aimed to describe the relationship between
    ileocolectomy, fecal BA, microbiota, and intestinal inflammation in inflammatory bowel disease (IBD).

    To this end, the researchers prospectively collected validated clinical and endoscopic evaluations
    of IBD.
    Compare fecal primary and secondary BA concentrations
    based on ileocolectomy and ileitis status.
    The main BA threshold
    for ileitis was assessed.
    Metagenomic sequencing analyzes the composition and function
    of microorganisms.
    The relationship between
    ileocolectomy, BA, and microbiota was assessed.

    The results showed the presence of ileocolectomy
    in 166 patients with primary and secondary elevated BA.
    For ileitis, only primary BA (795 nMol/g VS 398 nMol/g, p=0.
    009) was higher
    than without ileitis.
    The optimal primary BA threshold (≥228 nmol/g) was a predictor of ileitis (OR=2.
    3, p=0.
    04).

    Microbial diversity, Plostridium, and O-acetylhosanineaminocarboxypropyltransferase (MetY) decreased
    with increasing primary BA.
    Among patients undergoing ileocolectomy, only those with primary BA elevation have diversity, reduced Clostridium, and MetY
    .
    BA(≥228 nMol/g, p=0.
    0001) in patients undergoing ileocolectomy was associated with
    reduced Clostridium pristella.
    Patients who underwent ilecolectomy and low (<29.
    2 nmol/g) primary BA had similar Pralostridium (P=0.
    13)
    to those who did not.

    This study confirms that elevated primary bile acids are associated with ileitis, with decreased microbial diversity, Plostridia abundance, and enzyme abundance in MetY (acetic acid and L-methionine-producing enzymes expressed by F.
    prausnitzii), and are the only factors
    associated with these findings after ileocolectomy.

    Original source:

    Robert Battat.
    et al.
    Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease.
    Journal of Crohn's and Colitis.
    2022.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.